SGLT2 inhibitors and ketoacidosis in inpatients with diabetes

被引：0

|

作者：

Maharajan, V. ^{[1
]}

Cherian, T. ^{[1
]}

Jones, R. ^{[1
]}

Hards, K. ^{[1
]}

Anguelova, L. ^{[1
]}

Lumb, A. ^{[1
,2
]}

Rea, R. ^{[1
,2
]}

Owen, K. ^{[1
,2
]}

Tan, G. ^{[1
,2
]}

机构：

[1] Oxford Univ Hosp NHS FT, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England

[2] Oxford Univ Hosp, Hlth Res Biomed Res Ctr, Oxford Natl Inst, Oxford, England

来源：

DIABETIC MEDICINE | 2022年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P200

引用

收藏

页数：1

相关论文

共 50 条

[21] SGLT2 inhibitors in Japan: ARF, ketoacidosis and UTIs
Reactions Weekly, 2020, 1807 (1) : 11 - 11
[22] Pathogenesis of euglycemic ketoacidosis associated with SGLT2 inhibitors
Sitina, M.
Sramek, V
ANESTEZIOLOGIE A INTENZIVNI MEDICINA, 2024, 35 (02): : 98 - 103
[23] FAERS reports of diabetic ketoacidosis with SGLT2 inhibitors
Reactions Weekly, 2017, 1653 (1) : 7 - 7
[24] Individual SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis
Abrahami, Devin
D'Andrea, Elvira
Kim, Seoyoung C.
Wexler, Deborah J.
Paik, Julie M.
Patorno, Elisabetta
DIABETES, 2022, 71
[25] Labelling changes for SGLT2 inhibitors: ketoacidosis, UTIs
Reactions Weekly, 2015, 1582 (1) : 3 - 3
[26] HSA reviewing risk of ketoacidosis with SGLT2 inhibitors
Reactions Weekly, 2015, 1574 (1) : 5 - 5
[27] SGLT2 inhibitors may cause diabetic ketoacidosis
Reactions Weekly, 2015, 1553 (1) : 4 - 4
[28] Lessons from the bedside: ketoacidosis and SGLT2 inhibitors
Chow, Yvonne Y.
Worsley, Roisin
Topliss, Duncan J.
MEDICAL JOURNAL OF AUSTRALIA, 2016, 205 (04) : 191 - 192
[29] SGLT2 inhibitors increase risk of diabetic ketoacidosis
Reactions Weekly, 2017, 1656 (1) : 12 - 12
[30] SGLT2 inhibitors: diabetic ketoacidosis in the surgical setting
Reactions Weekly, 2020, 1789 (1) : 10 - 10

← 1 2 3 4 5 →